Results 101 to 110 of about 3,528 (147)

Safety of the BBIBP-CorV COVID-19 Vaccine in Relation to Adverse Clinical Outcomes in Newborns: A Prospective Cohort Study. [PDF]

Int J Womens Health
Muhetaier R, Zhang L, Ding G, Wang K, Li X.   +4 more
europepmc   +1 more source

Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine. [PDF]

Clin Infect Dis
Chissumba RM, Kwatra G, Ramgi P, Enosse M, Sigaúque A, Khosa C, Viegas E, Bule O, Langa J, Dhar N, Mukendi C, Langa D, Sevene E, Hermanus T, Manamela N, Richardson S, Moore P, Madhi S, Jani IV, SIVCOV study group .   +19 more
europepmc   +1 more source

False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19. [PDF]

Front Med (Lausanne)
Moya-Salazar J, Ciprian LY, Rojas-Zumaran V, Moya-Salazar B, Goicochea-Palomino EA, Contreras-Pulache H.   +5 more
europepmc   +1 more source

Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats. [PDF]

PLoS One, 2023
Teymoorzadeh M, Daneshfar N, Yazdanparast R.   +2 more
europepmc   +1 more source

Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers. [PDF]

Biomedicines
García AH, Mayora SJ, Medina C, Belisario IA, Martínez WY, Crespo FI, De Sanctis JB.   +6 more
europepmc   +1 more source

Immunogenicity and safety of the BBIBP-CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort. [PDF]

Immun Inflamm Dis, 2023
Zamani B, Moradi Hasan-Abad A, Piroozmand A, Dehghani M, Arfaatabar M, Motedayyen H.   +5 more
europepmc   +1 more source

Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination. [PDF]

Travel Med Infect Dis, 2023
Zhang Y, Guo X, Han S, Yao M, Zhang L, Zhao L, Zhang J, Jiang X, Zhang S, Pang B, Wang J, Wang S, Fang M, Liu X, Kou Z, Jiang X.   +15 more
europepmc   +1 more source

Upper extremity deep vein thrombosis following BBIBP-CorV COVID-19 vaccine (Sinopharm vaccine): A case report. [PDF]

Clin Case Rep, 2023
Riazi A, Faghih Dinevari M, Abbasian S, Jabbaripour Sarmadian A.   +3 more
europepmc   +1 more source

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing. [PDF]

Emerg Microbes Infect, 2023
Tong R, Luo L, Zhao Y, Sun M, Li R, Zhong J, Chen Y, Hu L, Li Z, Shi J, Lyu Y, Hu L, Guo X, Liu Q, Shuang T, Zhang C, Yuan A, Sun L, Zhang Z, Qian K, Chen L, Lin W, Chen AF, Wang F, Pu J.   +24 more
europepmc   +1 more source

Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study. [PDF]

BMJ Open
De Silva ST, Ediriweera DS, Wimalasena W, Kariyawasam M, Kosinna G, Bogoda G, Senaratne S, Rathnayake K, Weerarathna I, Premaratna R, Gunasena P.   +10 more
europepmc   +1 more source